Monitor the opening trade price on Nasdaq, as the direct listing process without underwriters creates price discovery risk. The toxic conversion feature on the Class C Preferred Shares (floor price stepping down to $1.00) will create persistent downward pressure on the common stock as the investor can convert at a discount to market. Watch for any delays in project financing for the $252M backlog, which is critical to the company's turnaround narrative.
Executive Summary
Roze AI Inc. filed Amendment No. 5 to its F-1 registration statement for a direct listing of up to 18,138,565 common shares for resale by existing shareholders on Nasdaq. The filing confirms a severe 72% revenue decline in 2025 to $2.3M from $8.2M in 2024, a net loss of $6.0M, and an auditor's going concern qualification. A concurrent $10.0M private placement of convertible preferred shares with a toxic floor-price reset feature (down to $1.00) provides critical liquidity but introduces massive potential dilution for common shareholders post-listing, while the company receives no proceeds from the direct listing itself.
Key Financial Metrics
Key Facts
- Direct listing of up to 18,138,565 common shares for resale by existing shareholders; company receives no proceeds.
- Revenue declined 72% YoY to $2,295,237 in 2025 from $8,225,475 in 2024.
- Net loss of $6,030,257 in 2025, compared to $1,444,257 in 2024.
- Auditor's going concern qualification; accumulated deficit of $16,754,384 as of Dec 31, 2025.
- $10.0M private placement of 1,250,000 Class C Preferred Shares at $8.00/share with toxic conversion features: conversion price is lower of $8.00 or 80% of lowest 5-day VWAP, with floor price stepping down from $4.00 to $1.00 over 120 days.
- CEO Young Jin Cho will control 61% of voting power post-listing, making the company a 'controlled company'.
- Cash and cash equivalents of $1,083,913 as of Dec 31, 2025; pro forma cash of $11.5M after the private placement.
- Backlog of $526.8M across 32 projects, but only $252.2M expected to break ground in next 12 months, subject to project financing.
- Total indebtedness of $6.45M as of Dec 31, 2025, including $1.99M in convertible debt.
- Company is a Canadian holding company with operations in South Korea; no VIE structure.
Financial Impact
72% revenue decline to $2.3M; net loss of $6.0M; $10.0M private placement with toxic conversion features; going concern qualification
Risk Factors
- Going concern risk: auditor has expressed substantial doubt about ability to continue as a going concern.
- Massive dilution risk: Class C Preferred Shares have a toxic floor-price reset feature down to $1.00, potentially converting into up to 12.5M common shares at $1.00 vs 1.56M at $8.00.
- Direct listing price discovery risk: no underwritten IPO, so opening price may be volatile and unsustainable.
- Controlled company risk: CEO holds 61% voting power, reducing minority shareholder protections.
- Revenue concentration and project financing risk: $252M backlog dependent on project financing that has not yet closed.
- South Korea construction market downturn may continue to delay project commencements.
- Substantial debt load of $6.45M with near-term maturities.
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1/A Filing (Primary) | 0001213900-26-100443 |
| Document: ea030550701ex3-3.htm | 0001213900-26-100443 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | EFFECT | — | awaiting T+20 | — | — |
Sep 16, 2026 5w ago | F-1/A | — | awaiting T+20 | — | — |
Aug 21, 2026 9w ago | F-1/A | — | awaiting T+20 | — | — |
Aug 11, 2026 10w ago | F-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers